NCT03301571

Brief Summary

Postoperative right ventricular (RV) dysfunction increases mortality and risk of cardiac failure after cardiac surgery substantially. A comprehensive understanding of this condition is paramount in order to achieve success in treatment and early diagnosis. This study has two main aims. Perioperative aim: To investigate correlations between changes in echocardiographic measurements and hemodynamic changes at baseline and following coronary artery bypass graft (CABG) surgery. Postoperative aim: To evaluate changes in haemodynamics and echocardiographic parameters during separate physiological interventions (increase in preload/afterload, oxygen fraction, pacing modes (AAI/DDD/VVI)).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 4, 2017

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 19, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 4, 2017

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 5, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 5, 2017

Completed
Last Updated

January 9, 2018

Status Verified

January 1, 2018

Enrollment Period

5 months

First QC Date

September 19, 2017

Last Update Submit

January 8, 2018

Conditions

Keywords

Coronary artery bypass graftEchocardiography

Outcome Measures

Primary Outcomes (1)

  • Change in right ventricular function during CABG assessed with TAPSE

    Assessing the change in RV function during CABG surgery

    During a standard CABG operation

Secondary Outcomes (26)

  • Right ventricular function assessed with TAPSE after each intervention

    Immediate postoperative period

  • Change in cardiac output measured with Swan-Ganz during CABG

    During a standard CABG operation

  • Change in cardiac output measured with Swan-Ganz after each intervention

    Immediate postoperative period

  • Response in right ventricular function parameter S' to each intervention

    Immediate postoperative period

  • Response in right ventricular function parameter S' during CABG

    During a standard CABG operation

  • +21 more secondary outcomes

Study Arms (1)

All patients

OTHER

All patients will receive the treatment (CABG) and postoperatively three different interventions: 1. Change in preload and afterload 2. Change in inspired oxygen 3. Change in pacemaker modes

Other: Change in preload and afterloadOther: Inspired oxygenOther: Pacemaker mode

Interventions

Afterload: Three levels of positive end-expiratory pressure (PEEP) will be examined post-operatively: 0 cm H20, 5 cm H2O, 10 cm H2O Preload: Trendelenburg position for 5 minutes will be investigated

All patients

Following fractions of inspired O2 will be investigated: 0.5 and 1.0 for 10 minutes respectively

All patients

Following pacemaker settings will be investigated: Atrioventricular pacing 10 bpm over the patients' intrinsic rhythm, atrial pacing 10 bpm over the patients' intrinsic rhythm, ventricular pacing 10 bpm over the patients' intrinsic rhythm

All patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective coronary artery bypass graft patients
  • Normal left ventricular function defined as LVEF over 50 % on TTE preoperatively

You may not qualify if:

  • Pre-existing right ventricular malformations
  • Severe right ventricular impairment preoperatively
  • Pre-existing non-sinus rhythm
  • Pre-existing mitral valve stenosis or severe regurgitation
  • Pre-existing pulmonary hypertension
  • Pre-existing tricuspid valve stenosis or severe regurgitation
  • Patients with contraindication to TEE probe placement such as oesophageal stricture or obstruction
  • Patients with contraindication to Swan-Ganz catheter placement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rigshospitalet

Copenhagen, Capital Region, 2100, Denmark

Location

MeSH Terms

Conditions

Ventricular Dysfunction, Right

Condition Hierarchy (Ancestors)

Ventricular DysfunctionHeart DiseasesCardiovascular Diseases

Study Officials

  • Lars Grønlykke, MD

    Rigshospitalet, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: All patients will receive the same interventions
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator, MD

Study Record Dates

First Submitted

September 19, 2017

First Posted

October 4, 2017

Study Start

May 4, 2017

Primary Completion

October 5, 2017

Study Completion

October 5, 2017

Last Updated

January 9, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share

Locations